Christopher Downs Cns Pharmaceuticals, Inc. (CNSP) insider trading activity

Christopher Downs is Chief Financial Officer of CNS Pharmaceuticals, Inc.. Currently has a direct ownership of 103,438 shares of CNSP, which is worth approximately $11,378. The most recent transaction as insider was on Feb 01, 2024, when has been sold 66,666 shares (Common Stock) at a price of $0.3 per share, resulting in proceeds of $19,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 103K

0% 3M change

181.3% 12M change

Total Value Held $11,378

Christopher Downs Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 01 2024	BUY Open market or private purchase	$19,999 $0.3 p/Share	66,666 Added 39.19%	103,438 Common Stock
Aug 22 2023	BUY Open market or private purchase	$34,290 $1.27 p/Share	27,000 Added 42.34%	36,772 Common Stock
Apr 28 2023	BUY Exercise of conversion of derivative security	-	521 Added 5.06%	9,772 Common Stock
Apr 17 2023	BUY Open market or private purchase	$9,920 $3.2 p/Share	3,100 Added 25.1%	9,251 Common Stock
Mar 11 2022	BUY Grant, award, or other acquisition	$10,230 $0.31 p/Share	33,000 Added 15.17%	184,500 Common Stock
Dec 06 2021	BUY Open market or private purchase	$4,700 $0.94 p/Share	5,000 Added 3.19%	151,500 Common Stock
Nov 19 2021	BUY Open market or private purchase	$5,175 $1.15 p/Share	4,500 Added 2.98%	146,500 Common Stock

Also insider at

EBET

EBET, Inc. Consumer Cyclical

Director